Information on the target
Astorg has successfully completed the acquisition of the global microbiology business from Thermo Fisher Scientific, marking the establishment of an independent global diagnostics specialist. The newly independent company will be led by Chief Executive Officer Dirk Bontridder and is set to launch under a new corporate brand later in 2026. This transaction positions the Microbiology business as a foundational platform for global microbiology diagnostics, catering to the clinical, food safety, and pharmaceutical markets.
The Microbiology business is recognized as a global provider of diagnostic consumables and equipment utilized in microbiological testing across various applications. With a customer base exceeding 15,000 across more than 100 countries, the company employs approximately 2,400 individuals across 13 manufacturing and R&D sites worldwide.
Industry overview in the target’s specific country
The Bio Diagnostics & Testing industry in the target country is experiencing significant growth, driven by increasing demand for accurate and timely diagnostic solutions. The rise in infectious diseases, coupled with a growing emphasis on food safety and quality assurance in the pharmaceutical sector, has propelled the need for advanced microbiological testing solutions. As a result, companies in this sector are focusing on innovation and the development of new diagnostic technologies to meet these demands.
Furthermore, regulatory frameworks in the country are becoming more stringent, necessitating higher standards for diagnostic testing and quality control. This has led to increased investment in research and development, as companies strive to comply with regulations while also enhancing their product offerings. The competitive landscape is characterized by a mix of established players and emerging startups, all vying for market share in a rapidly evolving environment.
In addition, the integration of digital technologies and automation in laboratory processes is transforming the Bio Diagnostics & Testing industry. Companies are leveraging advancements in artificial intelligence and machine learning to improve diagnostic accuracy and efficiency. This trend is expected to continue, further driving innovation and growth within the sector.
Overall, the Bio Diagnostics & Testing industry in the target country is poised for robust expansion, supported by tech…